Company / EPS (Basic)
INOVIO PHARMACEUTICALS, INC. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$3.95
FY2025
5-year range
-$17.45 / -$1.07
FY2021-FY2025
Trend
+35.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has fluctuated over the past 10 years, ranging from $-17.45 in FY2023 to $-0.43 in FY2017.
Based on SEC 10-K filings.
-3.95 in FY2025.
Improved from $-17.45 to $-3.95 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 35.1% year-over-year.
- Peak eps (basic) was recorded in FY2017.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.95 | +35.1% |
| FY2024 | -$6.09 | +65.1% |
| FY2023 | -$17.45 | -1530.8% |
| FY2022 | -$1.07 | +11.6% |
| FY2021 | -$1.21 | -45.8% |
| FY2020 | -$0.83 | +23.1% |
| FY2019 | -$1.08 | -6.9% |
| FY2018 | -$1.01 | -134.9% |
| FY2017 | -$0.43 | +29.5% |
| FY2016 | -$0.61 | +57.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026